Laboratory Testing to Rule Out PCOS
To rule out PCOS, order an early morning total testosterone, pelvic ultrasound, TSH, prolactin, and early morning 17-hydroxyprogesterone to exclude mimicking conditions, while documenting clinical features of hyperandrogenism and menstrual irregularity. 1, 2
Core Diagnostic Laboratory Panel
The Endocrine Society guidelines establish a systematic approach to laboratory evaluation when PCOS is suspected 1:
Essential Initial Tests
Early morning total testosterone (drawn days 4-10 of menstrual cycle in regularly cycling women)
- This is the initial androgen screening test 1
- If normal but clinical suspicion remains high (risk factors present, progressive hirsutism), measure both total and free testosterone in a reliable specialty laboratory 1
- Critical caveat: Many commercial laboratories have inaccurate normal ranges for female testosterone levels—use a laboratory with demonstrated proficiency in female androgen measurement 3
Pelvic ultrasonography
Mandatory Exclusion Tests
These must be ordered to rule out conditions that mimic PCOS 1, 2:
- TSH - excludes thyroid dysfunction causing menstrual irregularity
- Prolactin - excludes hyperprolactinemia (can present with amenorrhea or hirsutism)
- Early morning follicular phase 17-hydroxyprogesterone - excludes nonclassic congenital adrenal hyperplasia (21-hydroxylase deficiency)
- Particularly important in high-risk ethnic groups: Ashkenazi Jews (1 in 27), Hispanics (1 in 40), Slavics (1 in 50), or with positive family history 1
Additional Androgen Assessment
- DHEAS (dehydroepiandrosterone sulfate) - helps identify adrenal source of hyperandrogenism 1, 4
- Substantially elevated levels suggest adrenocortical neoplasm
Conditional Testing Based on Clinical Presentation
If specific clinical features are present, add 1:
- Assessment for Cushing's syndrome - if proximal muscle weakness, easy bruising, or striae present
- Assessment for acromegaly - if frontal bossing or acral enlargement present
- Pregnancy test - in patients with amenorrhea
Metabolic Screening (Not for Diagnosis, But for Risk Assessment)
While not required for PCOS diagnosis, these assess associated metabolic risks 4:
- Fasting glucose and insulin - evaluates insulin resistance
- Lipid panel - assesses cardiovascular risk
- Mid-luteal progesterone - documents anovulation (level <6 nmol/L indicates anovulation) 4
Diagnostic Algorithm
PCOS diagnosis requires 2 of 3 criteria (Rotterdam criteria) 2:
- Androgen excess (clinical or biochemical)
- Ovulatory dysfunction
- Polycystic ovaries on ultrasound
After exclusion of mimicking disorders (thyroid disease, hyperprolactinemia, nonclassic CAH) 2
Critical Pitfalls to Avoid
Laboratory quality matters: Commercial labs often report inaccurate testosterone reference ranges for women—the same value may be labeled normal to high depending on the lab 3. Use specialty laboratories with validated female reference ranges.
Timing is crucial: Testosterone should be measured early morning during follicular phase (days 4-10) in regularly cycling women 1
Don't over-rely on single tests: If total testosterone is normal but clinical features strongly suggest hyperandrogenism, measure free testosterone in a reliable laboratory 1
Age considerations: Diagnosis is problematic in perimenarchal and perimenopausal women due to normal physiologic changes in androgens and ovarian morphology 2
Polycystic ovaries alone are insufficient: 17-22% of normal women have polycystic ovarian morphology without PCOS 4. The diagnosis requires clinical or biochemical evidence of dysfunction.
Strength of Evidence
The recommendations are based primarily on the 2008 Endocrine Society Clinical Practice Guideline 1 and the 2013 Endocrine Society PCOS Guideline 2, which represent the highest quality guideline evidence available. These guidelines emphasize that PCOS remains a diagnosis of exclusion—the laboratory workup serves both to identify hyperandrogenism and to systematically exclude other treatable conditions with similar presentations.